These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


312 related items for PubMed ID: 19831582

  • 1. Chemically modified cell-penetrating peptides for the delivery of nucleic acids.
    Mäe M, Andaloussi SE, Lehto T, Langel U.
    Expert Opin Drug Deliv; 2009 Nov; 6(11):1195-205. PubMed ID: 19831582
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.
    Deshayes S, Morris M, Heitz F, Divita G.
    Adv Drug Deliv Rev; 2008 Mar 01; 60(4-5):537-47. PubMed ID: 18037526
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Gateways and tools for drug delivery: endocytic pathways and the cellular dynamics of cell penetrating peptides.
    Jones AT.
    Int J Pharm; 2008 Apr 16; 354(1-2):34-8. PubMed ID: 18068916
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Delivery of nucleic acids with a stearylated (RxR)4 peptide using a non-covalent co-incubation strategy.
    Lehto T, Abes R, Oskolkov N, Suhorutsenko J, Copolovici DM, Mäger I, Viola JR, Simonson OE, Ezzat K, Guterstam P, Eriste E, Smith CI, Lebleu B, Samir El Andaloussi, Langel U.
    J Control Release; 2010 Jan 04; 141(1):42-51. PubMed ID: 19744531
    [Abstract] [Full Text] [Related]

  • 14. Cellular delivery of peptide nucleic acid by cell-penetrating peptides.
    Kilk K, Langel U.
    Methods Mol Biol; 2005 Jan 04; 298():131-41. PubMed ID: 16044544
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cell-penetrating peptides for drug delivery across membrane barriers.
    Foged C, Nielsen HM.
    Expert Opin Drug Deliv; 2008 Jan 04; 5(1):105-17. PubMed ID: 18095931
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Structural requirements for cellular uptake and antisense activity of peptide nucleic acids conjugated with various peptides.
    Wolf Y, Pritz S, Abes S, Bienert M, Lebleu B, Oehlke J.
    Biochemistry; 2006 Dec 19; 45(50):14944-54. PubMed ID: 17154532
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.